I think a major concern is the 'pricing deflation' whjch is being experienced by all pharma.
The plant being completes in NC,USA should help remove some costs; however im not sure how much price deflation will remain - and how this will impact the bottom line.
My gut tells me, short term it could be worse than expected, yet only based off my gut.
On the flip side im comfortable for myx as a long term holding and happy with management.
I would love to read more on price deflation / and even past cases in other sectors if any one could point me in the right direction?
Quantifying downside risks, page-4
-
- There are more pages in this discussion • 264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.36 |
Change
-0.160(3.54%) |
Mkt cap ! $370.9M | |||
| Open | High | Low | Value | Volume |
| $4.51 | $4.51 | $4.32 | $562.8K | 128.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.39 | 474 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |